Page last updated: 2024-08-24

irinotecan and Neoplasms, Cystic, Mucinous, and Serous

irinotecan has been researched along with Neoplasms, Cystic, Mucinous, and Serous in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Itoi, T; Kamisawa, T; Takaori, K; Wood, LD1

Reviews

1 review(s) available for irinotecan and Neoplasms, Cystic, Mucinous, and Serous

ArticleYear
Pancreatic cancer.
    Lancet (London, England), 2016, Jul-02, Volume: 388, Issue:10039

    Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Camptothecin; Carcinoembryonic Antigen; Carcinoma, Pancreatic Ductal; Deoxycytidine; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Fluorouracil; Gemcitabine; Genes, p16; Humans; Irinotecan; Leucovorin; Neoplasms, Cystic, Mucinous, and Serous; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pancreatectomy; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Smad4 Protein; Tumor Suppressor Protein p53

2016